Empagliflozin/Metformin Tablets 5/850 mg
Empagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Dongkwang Pharmaceutical Co., Ltd.
MFDS item code 202201377 · Approved 2022.04.04
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication is used to improve blood sugar control in adults with type 2 diabetes by assisting with dietary and exercise regimens. It is particularly administered to patients whose blood sugar is not adequately controlled, and may also be applicable to patients with cardiovascular diseases. The effectiveness and safety of the drug should be used in accordance with professional guidelines. Therefore, this medication effectively controls blood sugar and aids in the treatment of type 2 diabetes.
The recommended dose is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients whose blood glucose is not adequately controlled with metformin alone or in combination with other medicines such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional blood glucose control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin to this medicine should receive their current doses of empagliflozin and metformin. When this medicine is used in combination with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Drug Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose, take it as soon as you remember. However, do not take a double dose at one time; if this happens, skip the missed dose. Special Populations Patients with Renal Impairment No dose adjustment is necessary for patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with the individual components, empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine should be discontinued immediately (see Precautions for Use, 2. Contraindications, item 2)). Elderly Patients In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.
This medication is used to manage diabetes and helps with blood sugar control. This drug may cause a rare side effect called severe lactic acidosis, therefore, patients with poor kidney function or those experiencing severe infections, shock, or acute myocardial infarction should not use it. Additionally, caution is needed as hypoglycemia may occur when used alongside insulin or sulfonylureas. This medication is contraindicated in patients with moderate to severe kidney impairment, liver dysfunction, and in women who are pregnant or breastfeeding. Before and after undergoing tests using iodine contrast agents, this medication should be temporarily discontinued, and it should only be resumed once kidney function has been confirmed to be normal. Discontinue this medication within 48 hours before surgery, and resume once kidney function has returned to normal post-surgery. This medication may cause decreased fluid volume, so those in a dehydrated state or with gastrointestinal disorders should take special care. It may reduce vitamin B12 levels, hence it's advisable to routinely monitor vitamin B12 levels during long-term use. Alcohol intake may increase the risk of lactic acidosis, so excessive drinking should be avoided during treatment. This medication may increase the risk of urinary and genital infections, so immediate consultation with a physician is required upon the appearance of such symptoms. Hypoglycemic symptoms may occur, so especially if taken with insulin or sulfonylureas, blood sugar changes should be closely monitored. Elderly patients or those with impaired kidney function should regularly undergo kidney function tests, and dosage adjustments may be necessary. In the event of overdose, serious side effects like lactic acidosis may occur, hence strict adherence to dosage is necessary, and if unusual symptoms arise, immediate medical attention should be sought. Keep this medication out of reach of children and store it in its original container for safety.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent exposure to air or moisture, and maintained at room temperature between 1 to 30 degrees Celsius. This is to preserve the drug's efficacy and ensure safe usage.
White, biconvex, oval film-coated tablets with a yellowish hue
10 tablets/box[(10 tablets/PTP)×1], 60 tablets/box[(10 tablets/PTP)×6], 60 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Empagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Dongkwang Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.